Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metaglez Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Glipizide (2.5mg) + Metformin (400mg)

Overview Metaglez Tablet

Diabex Duo tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, Diabex Duo is part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Familiarize yourself with its symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Consistent meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are vital. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose checks are necessary, and your doctor might recommend blood tests to monitor blood cell counts and liver function.

Uses of Metaglez Tablet

Managing type 2 diabetes

Major Benefits of Metaglez Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metaglez Tablet with a meal.

Common Side effects of Metaglez Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Metaglez Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metaglez Tablet with a meal.

How Metaglez Tablet works:

Metaglez tablets contain a dual-action formulation of glipizide and metformin, both medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metaglez Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metaglez Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Metaglez Tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metaglez Tablet cautiously, potentially requiring dosage modification. Consult your physician. Metaglez Tablet is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metaglez Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; Metaglez Tablet is contraindicated in those with severe liver disease.

What if you forget to take Metaglez Tablet :

Should you forget a Metaglez Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metaglez Tablet

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Metaglez Tablet

Glipizide and Metformin, combined as Metaglez Tablet, manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when coupled with a healthy diet and regular physical activity. Glipizide stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 DM.
Taking Metaglez Tablets may result in common side effects such as low blood sugar (hypoglycemia), changes in taste perception, queasiness, abdominal discomfort, loose stools, headaches, and upper respiratory infections. Rare but potentially serious side effects, including lactic acidosis, are also possible. Prolonged use may additionally cause Vitamin B12 deficiency.
Indeed, Metaglez Tablet use may lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. It's advisable to keep readily available a source of glucose, such as glucose tablets, honey, or fruit juice.
Metaglez Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse effect is linked to metformin and contraindicated in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms can include muscular pain or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Metaglez Tablet and seek immediate medical attention.
Prolonged Metaglez Tablet use can indeed lead to Vitamin B12 deficiency. This is due to the medication's interference with Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may manifest as anemia, neurological issues including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, according to some studies, involve supplemental Vitamin B12 intake at least annually.
Patients with hypersensitivity to any ingredient or inactive substance in Metaglez Tablet should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, and those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Metaglez Tablet and alcohol is unsafe. This combination may dangerously reduce blood sugar (causing hypoglycemia) and heighten the risk of lactic acidosis.
Retain this medication in its original, sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and others.
Metaglez Tablet
4
MRP 5
15% off